BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
50 results:

  • 1. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Different oncological features of colorectal cancer codon-specific
    Ahn HM; Kim DW; Oh HJ; Kim HK; Lee HS; Lee TG; Shin HR; Yang IJ; Lee J; Suh JW; Oh HK; Kang SB
    World J Gastroenterol; 2023 Aug; 29(32):4883-4899. PubMed ID: 37701134
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
    Halalsheh H; Amer S; Sultan I
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
    Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MSH-5: malignant knee tumors timely detection index.
    Rivera-Saldívar G; Torres-González R; Cario-Méndez A; Técualt-Gómez R; Amaya-Zepeda RA; Alcántara-Corona A; Fuentes-Figueroa S
    Cir Cir; 2023; 91(2):146-152. PubMed ID: 37084299
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma.
    Wah NW; Mok Y; Omar N; Chang KTE; Tay TKY; Hue SS; Lee VKM
    Mod Pathol; 2023 Jun; 36(6):100127. PubMed ID: 36965331
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A contrast-enhanced MRI-based nomogram to identify lung metastasis in soft-tissue sarcoma: A multi-centre study.
    Hu Y; Wang H; Yue Z; Wang X; Wang Y; Luo Y; Jiang W
    Med Phys; 2023 May; 50(5):2961-2970. PubMed ID: 36433749
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Druggable host gene dependencies in primary effusion lymphoma.
    Kuehnle N; Gottwein E
    Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response.
    Persha HE; Kato S; De P; Adashek JJ; Sicklick JK; Subbiah V; Kurzrock R
    J Hematol Oncol; 2022 Aug; 15(1):119. PubMed ID: 36031605
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Soft tissue sarcoma: IVIM and DKI parameters correlate with Ki-67 labeling index on direct comparison of MRI and histopathological slices.
    Zhang K; Dai Y; Liu Y; Tao J; Pan Z; Xie L; Wang S
    Eur Radiol; 2022 Aug; 32(8):5659-5668. PubMed ID: 35278121
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Notoginsenoside R1 attenuates breast cancer progression by targeting ccnd2 and YBX3.
    Qin HL; Wang XJ; Yang BX; Du B; Yun XL
    Chin Med J (Engl); 2021 Jan; 134(5):546-554. PubMed ID: 33480613
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A population-level analysis of nonsquamous penile cancer: The importance of histology.
    Bhambhvani HP; Greenberg DR; Parham MJ; Eisenberg ML
    Urol Oncol; 2021 Feb; 39(2):136.e1-136.e10. PubMed ID: 33257222
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LncRNA FLVCR1-AS1 accelerates osteosarcoma cells to proliferate, migrate and invade via activating wnt/β-catenin pathway.
    Jiang S; Kong P; Liu X; Yuan C; Peng K; Liang Y
    J BUON; 2020; 25(4):2078-2085. PubMed ID: 33099956
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
    Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
    Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells.
    Hu C; Wang Y; Liu C; Shen R; Chen B; Sun K; Rao H; Ye L; Ye J; Tian S
    Med Sci Monit; 2020 Jul; 26():e924126. PubMed ID: 32683393
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. LncRNA KCNQ1OT1 acting as a ceRNA for miR-4458 enhances osteosarcoma progression by regulating ccnd2 expression.
    Wang M; Wang Z; Zhu X; Guan S; Liu Z
    In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):694-702. PubMed ID: 31392505
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High Burden of Non-communicable Diseases among a Young Slum Population in Haiti.
    McNairy ML; Tymejczyk O; Rivera V; Seo G; Dorélien A; Peck M; Petion J; Walsh K; Bolgrien A; Nash D; Pape J; Fitzgerald DW
    J Urban Health; 2019 Dec; 96(6):797-812. PubMed ID: 31218502
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
    Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
    Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Intravoxel incoherent motion and diffusion kurtosis imaging for discriminating soft tissue sarcoma from vascular anomalies.
    Wu G; Liu X; Xiong Y; Ran J; Li X
    Medicine (Baltimore); 2018 Dec; 97(50):e13641. PubMed ID: 30558056
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Dreno B; Thompson JF; Smithers BM; Santinami M; Jouary T; Gutzmer R; Levchenko E; Rutkowski P; Grob JJ; Korovin S; Drucis K; Grange F; Machet L; Hersey P; Krajsova I; Testori A; Conry R; Guillot B; Kruit WHJ; Demidov L; Thompson JA; Bondarenko I; Jaroszek J; Puig S; Cinat G; Hauschild A; Goeman JJ; van Houwelingen HC; Ulloa-Montoya F; Callegaro A; Dizier B; Spiessens B; Debois M; Brichard VG; Louahed J; Therasse P; Debruyne C; Kirkwood JM
    Lancet Oncol; 2018 Jul; 19(7):916-929. PubMed ID: 29908991
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.